Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagnosed DLBCL & Impact of Eligibility Criteria on Outcomes
Login to view comments.
Click here to Login
Malignant Hematology